- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Assisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030
Increasing demand for IVF, expanding fertility clinics, and innovation in reproductive technologies drive sustained growth at a 7.0% CAGR
Apr. 2, 2026 at 2:57pm
Got story updates? Submit your updates here. ›
The global Assisted Reproductive Technology (ART) market is projected to grow from $4.29 billion in 2025 to $6.02 billion by 2030, registering a robust CAGR of 7.0%. This rapid expansion is driven by rising infertility rates, evolving patient needs, and continuous innovation in fertility treatments such as preimplantation genetic testing, embryo cryopreservation, and enhanced in-vitro fertilization techniques.
Why it matters
As infertility becomes a growing global health concern, ART is transitioning from a niche solution to a mainstream medical necessity. For healthcare providers, investors, and policymakers, this market represents a critical intersection of innovation, demand, and long-term societal impact.
The details
Breakthroughs in ART technologies are improving success rates and clinical efficiency, not only increasing patient confidence but also expanding the addressable market by enabling treatment for complex infertility cases. However, the market faces constraints from ethical and regulatory complexities, including legal restrictions, high treatment costs, and ongoing debates surrounding embryo handling and surrogacy.
- The ART market is projected to grow from $4.29 billion in 2025 to $6.02 billion by 2030.
- The market is expected to register a CAGR of 7.0% during the forecast period.
The players
CooperSurgical Inc.
A leading company in the ART market, leveraging both organic and inorganic strategies to strengthen its market position.
FUJIFILM Irvine Scientific
A prominent player in the ART market, offering a range of products and services to support fertility treatments.
Vitrolife
A Swedish company that is a key player in the ART market, providing advanced reproductive technologies and solutions.
Hamilton Thorne
A US-based company that is a leading provider of ART equipment and technologies, including instruments for IVF and embryo culture.
Cook Medical Inc.
A US-based company that is a major supplier of medical devices and technologies for the ART market.
What’s next
The ART market is expected to continue its strong growth trajectory, driven by increasing demand for fertility treatments, technological advancements, and expanding healthcare infrastructure, particularly in developing regions. Regulatory and ethical considerations will remain key factors shaping the market's evolution.
The takeaway
The rapid growth of the ART market highlights the growing importance of assisted reproductive technologies in addressing the global challenge of infertility. As the market expands, healthcare providers, investors, and policymakers will need to navigate the complex landscape of innovation, regulation, and societal impact to ensure that these advanced treatments are accessible and effective for those in need.
